Calcium and Nateglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Nateglinide (nateglinide). Common drug interactions include discomfort among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Nateglinide. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

What is Nateglinide?

Nateglinide has active ingredients of nateglinide. It is often used in type 2 diabetes. eHealthMe is studying from 1,771 Nateglinide users. Check the latest studies of Nateglinide.



On Jul, 12, 2026

47 people who take Calcium and Nateglinide together, and have interactions are studied.

Calcium and Nateglinide drug interactions.

What are the common drug interactions of Calcium and Nateglinide, by gender? *:

female:

  1. Discomfort
  2. Disease progression
  3. Disease recurrence
  4. Fall
  5. Feeling hot
  6. Flushing (the warm, red condition of human skin)
  7. Gait disturbance
  8. Gangrene (body tissue dies)
  9. Glaucoma (increased fluid pressure in the eye with vision loss)
  10. Haematemesis (vomiting of blood)

male:

  1. White blood cell count decreased
  2. Atrioventricular block complete (heart block complete)
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Flatulence (flatus expelled through the anus)
  6. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  7. Neoplasm progression (growth of tumour)
  8. Oedema peripheral (superficial swelling)
  9. Arthralgia (joint pain)
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

What are the common drug interactions of Calcium and Nateglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Cataract (clouding of the lens inside the eye)
  3. Gastric infection (infection of stomach)
  4. Gastric ulcer (stomach ulcer)
  5. Haematochezia (passage of stools containing blood)
  6. Pustular psoriasis (raised bumps on the skin that are filled with pus)
  7. Skin exfoliation (removal of the oldest dead skin cells)
  8. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  9. Cholecystitis (infection of gallbladder)
  10. Fear

50-59:

  1. Pyrexia (fever)
  2. Rales (an abnormal respiratory sound characterized by fine crackles)
  3. Arthralgia (joint pain)
  4. Abdominal pain
  5. Chronic kidney disease
  6. Renal haematoma (blood collection in kidney)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Interstitial lung disease
  10. White blood cell count decreased

60+:

  1. Fatigue (feeling of tiredness)
  2. Flatulence (flatus expelled through the anus)
  3. Cataract (clouding of the lens inside the eye)
  4. Diarrhoea
  5. Vertigo
  6. Atrioventricular block complete (heart block complete)
  7. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  8. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  9. Hyperglycaemia (high blood sugar)
  10. Injection site pain

What are the existing conditions these people have? *

  1. Diabetes: 13 people, 27.66%
  2. High Blood Pressure: 6 people, 12.77%
  3. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 12.77%
  4. Breast Cancer: 6 people, 12.77%
  5. Multiple Myeloma (cancer of the plasma cells): 4 people, 8.51%
  6. High Blood Cholesterol: 4 people, 8.51%
  7. Stress And Anxiety: 3 people, 6.38%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 6.38%
  9. Prostate Cancer: 3 people, 6.38%
  10. Neuropathy Peripheral (surface nerve damage): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Nateglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calcium and Nateglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nateglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nateglinide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcium and nateglinide (the active ingredients of Calcium and Nateglinide, respectively), and Calcium and Nateglinide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: